$LCLN

Lawson Lawrence James III sold (to issuer) 5,332,996 shares of LCLN

Lawson Lawrence James III sold (to issuer) 5,332,996 shares of Lincoln International, Inc. (LCLN) on 2026-05-21.

Original reporting
SEC EDGAR · Lawson Lawrence James III
Published May 26, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LCLN
Neutral
medium confidence
Mentioned
$LCLN
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LCLNNeutralMed
01

Why it matters

Because the transaction is to the issuer and the price/value are not disclosed, it is more likely a liquidity/plan execution event than a direct signal about near-term earnings power.

02

Market read

Traders may monitor for follow-on insider activity or buyback-related flows, but there is no disclosed fundamental catalyst in the filing.

03

What to watch

No 10b5-1 plan is indicated, but the filing also lacks disclosed price/value, limiting inference about valuation or conviction.

Relevance 7/10Timing: Immediate (filed 2026-05-26; transaction dated 2026-05-21).

Background

The filing is an SEC Form 4 insider transaction for Lincoln International, Inc. involving a director/10% owner sale to the issuer (code D).

Company-level read

Ticker impact

$LCLNNeutralMedium confidence
Context

Lincoln International disclosed an insider sale to the issuer of 5,332,996 shares by a director/10% owner on 2026-05-21.

Expected impact

Low-to-moderate near-term downside bias possible; magnitude likely limited because price is undisclosed and it’s a sale to issuer.

Evidence & confidence

Form 4 shows a director/10% owner transaction (code D) with no disclosed price and no stated link to earnings, guidance, or corporate actions; however, size is notable and can affect short-term perception.

Market effects

Minimal; this is company-specific insider activity without disclosed sector-wide signal.

Minimal; no geographic or cross-border catalyst mentioned.

Minimal; no international transaction or regulatory development cited.

Counterpoint

A code D sale to issuer can reflect routine buyback participation or pre-arranged mechanics, so the market may overreact to the headline size.

Key entities

  • Lincoln International, Inc.

    Subject of the insider Form 4: director/10% owner sold 5,332,996 shares to the issuer on 2026-05-21.

  • Lawson Lawrence James III

    Director and 10% owner who executed the sale to the issuer; holdings after transaction were 15,784,204 shares.

Related articles

$LCLNMedAI 8/10

Lincoln International Reports Second Quarter 2026 Financial Results

Lincoln International (NYSE: LCLN) reported Q2 2026 results: total revenue $225.7 million, up 51% year over year, and adjusted net income $28.7 million, or $0.26 adjusted diluted EPS. GAAP net income was $0.5 million. The firm declared a $0.07 per share dividend for Q3 2026 and reported $250.6 million cash and $101.9 million long-term debt as of June 30, 2026.

$LCLNMed

Lincoln International, Inc. (LCLN): Results of Operations and Financial Condition

Lincoln International, Inc. (LCLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsreleaseq22026_draft.htm EX-99.1 Document Lincoln International Reports Second Quarter 2026 Financial Results • Record second quarter and first half revenues of $225.7 million and $383.5 million, up 51% and 36%, respectively, compared to the prior-year periods •